Astigmatism Market Report 2026

The astigmatism market size has grown strongly in recent years. It will grow from $3.21 billion in 2025 to $3.41 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of refractive errors, increased awareness of vision correction options, expansion of ophthalmic clinics, availability of affordable corrective lenses, improvements in diagnostic accuracy.

The astigmatism market size is expected to see strong growth in the next few years. It will grow to $4.3 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing demand for personalized vision care, rising adoption of laser-based corrective procedures, expansion of tele-ophthalmology services, growing focus on preventive eye care, increasing use of ai-assisted diagnostics. Major trends in the forecast period include increasing adoption of customized corrective lenses, rising use of advanced diagnostic imaging tools, growing preference for minimally invasive vision correction, expansion of digital eye testing solutions, enhanced focus on early vision screening.

The rising prevalence of vision impairment is expected to drive the growth of the astigmatism market in the coming years. Vision impairment is a condition in which an individual experiences partial or complete loss of sight that cannot be fully corrected with glasses, contact lenses, or medical treatment. The increasing prevalence of vision impairment is fueled by an aging population, rising cases of diabetes and eye diseases, excessive screen exposure, and limited access to eye care in certain regions. Astigmatism contributes to vision impairment by causing blurred or distorted vision due to an irregular shape of the cornea or lens, which interferes with the proper focus of light on the retina. For example, in August 2024, according to the World Health Organization, a U.S.-based national agency reported that at least 2.2 billion people worldwide have a near or distance vision impairment. Additionally, it is estimated that globally only 36% of individuals with distance vision impairment from refractive errors and only 17% of those with vision impairment due to cataracts have received proper intervention. Consequently, the rising prevalence of vision impairment is fueling the growth of the astigmatism market.

Major companies in the astigmatism market are concentrating on developing advanced technologies, such as water gradient technology, to improve contact lens comfort, enhance moisture retention, and provide clearer vision for people with astigmatism. Water gradient technology is a contact lens design that gradually increases water content from the core to the surface, promoting better moisture retention and comfort. For example, in January 2023, Alcon Inc., a Switzerland-based pharmaceutical and medical device company, introduced TOTAL30 for Astigmatism. This innovative product is the first reusable contact lens made with water gradient material, specifically created for astigmatic wearers. Studies indicate that comfort plays a crucial role in both the lens-wearing experience and customer loyalty.

In January 2024, STAAR Surgical Company, a US-based manufacturer and marketer of implantable lenses and companion delivery systems for the eye, formed a partnership with Sharpe Vision to improve access to EVO ICL lenses. This collaboration emphasizes joint marketing and educational efforts to raise awareness and increase availability for eligible patients at Sharpe Vision clinics. STAAR will also offer clinical and practice development support. Sharpe Vision is a US-based company dedicated to providing advanced vision correction services, including laser eye surgery for conditions such as nearsightedness, farsightedness, astigmatism, and presbyopia.

Major companies operating in the astigmatism market are EssilorLuxottica SA, Novartis AG, HOYA Corporation, Alcon Inc, STAAR Surgical Company, Menicon Co Ltd, Rayner Intraocular Lenses Limited, Ophtec BV, Shamir Optical Industry Ltd, SEED Co Ltd, Visionary Optics LLC, Santen Pharmaceutical Co Ltd, Carl Zeiss AG, NIDEK Co Ltd, Topcon Corporation, Ziemer Ophthalmic Systems AG, SCHWIND eye-tech-solutions GmbH, BVI Medical, LENSAR Inc, Avedro Inc.

North America was the largest region in the astigmatism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the astigmatism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the astigmatism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the astigmatism market by increasing costs of imported optical equipment, diagnostic devices, laser surgery systems, and precision lens manufacturing materials. Hospitals and eye clinics in North America and Europe are most affected due to dependence on imported ophthalmic technologies, while Asia-Pacific faces higher costs for exporting lenses and surgical equipment. These tariffs are increasing treatment costs and delaying technology upgrades. However, they are also encouraging domestic lens manufacturing, localized assembly of diagnostic systems, and regional innovation in cost-efficient vision correction technologies.

The astigmatism market research report is one of a series of new reports that provides astigmatism market statistics, including astigmatism industry global market size, regional shares, competitors with a astigmatism market share, detailed astigmatism market segments, market trends and opportunities, and any further data you may need to thrive in the astigmatism industry. This astigmatism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Astigmatism is a refractive error of the eye in which the cornea or lens has an irregular shape, resulting in blurred or distorted vision. It happens when light entering the eye is not focused correctly on the retina, causing difficulty in seeing fine details at any distance.

The primary forms of astigmatism include myopic astigmatism, hyperopic astigmatism, mixed astigmatism, and other variants. Myopic astigmatism is a refractive error in which the cornea or lens has an irregular shape, resulting in blurred vision for both near and distant objects, along with a nearsightedness (myopia) component. A range of treatments is available, such as corrective lenses, orthokeratology, surgeries, and more, with major end users being hospitals, clinics, and others.

The astigmatism market consists of revenues earned by entities by providing services such as refractive surgery, diagnostic services, and vision therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The astigmatism market also includes sales of eyeglasses and contact lenses, astigmatism-specific eye care products, surgical equipment, and optical devices and tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.